Wells Fargo & Company Immix Biopharma, Inc. Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 330 shares of IMMX stock, worth $877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
330
Previous 330
-0.0%
Holding current value
$877
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IMMX
# of Institutions
25Shares Held
3.35MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY850KShares$2.26 Million0.49% of portfolio
-
Cable Car Capital LLC San Francisco, CA779KShares$2.07 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA699KShares$1.86 Million0.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$1.08 Million11.13% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$427,5730.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $37M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...